Thierry de Revel

Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study

Sylvie Castaigné, Cécile Pautas, Christine Terré et al. · The Lancet · 2012 · 995 citations

Medicine, Hematology, Pharmacology +10

High efficacy and safety profile of fractionated doses of Mylotarg as induction therapy in patients with relapsed acute myeloblastic leukemia: a prospective study of the alfa group

A.-L. Taksin, Ollivier Legrand, Emmanuel Raffoux et al. · Leukemia · 2006 · 288 citations

Medicine, Oncology, Pharmacology +10

New Approach to Radiation Burn treatment by Dosimetry-Guided Surgery Combined with Autologous Mesenchymal Stem Cell Therapy

J-J Lataillade, Christelle Doucet, É. Bey et al. · Regenerative Medicine · 2007 · 277 citations

Medicine, Plastic Surgery, Surgery +16

Prognostic Impact of Isocitrate Dehydrogenase Enzyme Isoforms 1 and 2 Mutations in Acute Myeloid Leukemia: A Study by the Acute Leukemia French Association Group

Nicolas Boissel, Olivier Nibourel, Aline Renneville et al. · Journal of Clinical Oncology · 2010 · 217 citations

Medicine, Molecular Genetics, Oncology +14

Randomized Study of Intensified Anthracycline Doses for Induction and Recombinant Interleukin-2 for Maintenance in Patients With Acute Myeloid Leukemia Age 50 to 70 Years: Results of the ALFA-9801 Study

Cécile Pautas, Fatiha Merabet, Xavier Thomas et al. · Journal of Clinical Oncology · 2010 · 217 citations · Full text

Pharmacy, Oncology, Pharmacology +16